Evidence map›Paper›PMID 40775312›Full record

ArticleBMC medical informatics and decision making2025

Remote clinical decision support tool for Parkinson's disease assessment using a novel approach that combines AI and clinical knowledge.

Harel Rom, Ori Peleg, Yovel Rom, Anat Mirelman, Gaddi Blumrosen, Inbal Maidan

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Harel RomLaboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, 64239, Israel.
Ori PelegLaboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, 64239, Israel.
Yovel RomAEYE Health, Tel Aviv, Israel.
Anat MirelmanLaboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, 64239, Israel.
Gaddi BlumrosenFaculty of Digital Medical Technologies, Holon Institute of Technology (HIT), Holon, Israel.
Inbal MaidanLaboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, 64239, Israel. inbalm@tlvmc.gov.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly diagnosis of Parkinson's disease (PD) can assist in designing efficient treatments. Reduced facial expressions are considered a hallmark of PD, making advanced artificial intelligence (AI) image processing a potential non-invasive clinical decision support tool for PD detection. This study aims to determine the sensitivity of image-to-text AI, which matches facial frames recorded in home settings with descriptions of PD facial expressions, in identifying patients with PD.

methodsFacial image of 67 PD patients and 52 healthy-controls (HCs) were collected via standard video recording. Using clinical knowledge, we compiled descriptive sentences detailing facial characteristics associated with PD. The facial images were analyzed with OpenAI's CLIP model to generate probability scores, indicating the likelihood of each image matching the PD-related descriptions. These scores were used in an XGBoost model to identify PD patients based on the total, motor, and facial-expression item of the MDS-UPDRS, a common scale for assessing disease severity.

resultsThe image-to-text AI technology showed the best results in identifying PD patients based on the facial expression item (AUC = 0.78 ± 0.05), especially for those with 'mild' facial symptoms (AUC = 0.87 ± 0.04). The motor MDS-UPDRS score followed (AUC = 0.69 ± 0.05), while the total MDS-UPDRS score showed the lowest performance in identifying PD patients (AUC = 0.59 ± 0.05). PD matching probabilities between facial images and sentences revealed significant correlations across all MDS-UPDRS components (r > 0.23, p < 0.0001).

conclusionsOur results demonstrate the feasibility of using advanced AI in a clinical decision support tool for PD diagnosis, suggesting a novel approach for home-based screening to identify PD patients. This method represents a significant innovation, transforming clinical knowledge into practical algorithms that can serve as effective screening tools. CLINICAL TRIAL NUMBER: MOH_2023-04-16_012535.

Indexed as

Artificial IntelligenceDecision Support Systems, ClinicalFacial ExpressionParkinson DiseaseAgedFemaleHumansMaleMiddle AgedArtificial intelligence (AI)Facial-expressionParkinson’s disease (PD)

Identifiers

PMID40775312
PMCPMC12329937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.